Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Balance Sheet
Balance Sheet Decomposition
Phathom Pharmaceuticals Inc
Current Assets | 397.4m |
Cash & Short-Term Investments | 381.4m |
Receivables | 1.6m |
Other Current Assets | 14.4m |
Non-Current Assets | 16.4m |
PP&E | 3.6m |
Other Non-Current Assets | 12.8m |
Current Liabilities | 38.8m |
Accounts Payable | 12.6m |
Accrued Liabilities | 19.1m |
Other Current Liabilities | 7.1m |
Non-Current Liabilities | 447.8m |
Long-Term Debt | 437.7m |
Other Non-Current Liabilities | 10.2m |
Balance Sheet
Phathom Pharmaceuticals Inc
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
1
|
244
|
288
|
183
|
155
|
381
|
|
Cash Equivalents |
1
|
244
|
288
|
183
|
155
|
381
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
|
Other Current Assets |
0
|
12
|
4
|
3
|
5
|
13
|
|
Total Current Assets |
1
|
256
|
291
|
187
|
161
|
397
|
|
PP&E Net |
0
|
1
|
3
|
3
|
4
|
4
|
|
PP&E Gross |
0
|
1
|
3
|
3
|
4
|
4
|
|
Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
2
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
13
|
|
Total Assets |
1
N/A
|
257
+28 478%
|
295
+15%
|
189
-36%
|
165
-13%
|
414
+151%
|
|
Liabilities | |||||||
Accounts Payable |
0
|
1
|
17
|
5
|
10
|
13
|
|
Accrued Liabilities |
0
|
3
|
31
|
14
|
16
|
19
|
|
Short-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
7
|
0
|
0
|
7
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
2
|
4
|
56
|
19
|
26
|
39
|
|
Long-Term Debt |
0
|
23
|
40
|
90
|
205
|
438
|
|
Other Liabilities |
0
|
3
|
6
|
9
|
9
|
10
|
|
Total Liabilities |
2
N/A
|
29
+1 227%
|
101
+245%
|
117
+16%
|
240
+104%
|
487
+103%
|
|
Equity | |||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
1
|
256
|
386
|
529
|
727
|
929
|
|
Additional Paid In Capital |
0
|
484
|
580
|
602
|
652
|
856
|
|
Total Equity |
1
N/A
|
228
N/A
|
194
-15%
|
72
-63%
|
75
N/A
|
73
+3%
|
|
Total Liabilities & Equity |
1
N/A
|
257
+28 478%
|
295
+15%
|
189
-36%
|
165
-13%
|
414
+151%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
26
|
25
|
29
|
31
|
42
|
58
|